Skip to main content
Log in

Genetisches Screening bei Kardiomyopathien

  • Published:
Zeitschrift für Kardiologie Aims and scope Submit manuscript


Cardiomyopathies comprise a heterogenous group of primary heart muscle discorders with a strong genetic component. Nearly all cases of hypertrophic cardiomyopathy and at least 20–30% of cases with dilated cardiomyopathy are due to autosomal dominant mutations. The extent of genetic factors for arrhythmogenic right ventricular and restrictive cardiomyopathy is less clear. Recent studies have demonstrated that genetic causes of all cardiomyopathies are highly heterogenous with more than 25 disease gene loci. Although the ability to diagnose cardiomyopathies at the molecular level has advanced, our understanding of disease pathways and the knowledge of individual diseases causing mutations has had little impact on the clinical management of patients. Once current technical limitations for large-scale mutation analysis are overcome, broad genotype/phenotype correlation studies may answer important clinical issues such as the precise relation between distinct mutations and the risk of sudden death, course of the disease and treatment of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations


Additional information

Eingegangen: 15. Februar 2000 Akzeptiert: 29. März 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thierfelder, L. Genetisches Screening bei Kardiomyopathien. Z Kardiol 89, 638–640 (2000).

Download citation

  • Issue Date:

  • DOI: